Difference between revisions of "Active surveillance"
From DolceraWiki
Sonal.pingle (Talk | contribs) |
Sonal.pingle (Talk | contribs) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | To go back to the previous page, click [http://dolcera.com/wiki/index.php?title=Prostate_cancer_details#Treatment.2FManagement here] | ||
| + | <br> | ||
| + | <br> | ||
| + | |||
| + | |||
| + | |||
* Active surveillance refers to observation and regular monitoring without invasive treatment. In the context of prostate disease this usually comprises regular PSA blood tests and prostate biopsies. Active surveillance is often used when an early stage, slow-growing prostate cancer is suspected. However, watchful waiting may also be suggested when the risks of surgery, radiation therapy, or hormonal therapy outweigh the possible benefits. | * Active surveillance refers to observation and regular monitoring without invasive treatment. In the context of prostate disease this usually comprises regular PSA blood tests and prostate biopsies. Active surveillance is often used when an early stage, slow-growing prostate cancer is suspected. However, watchful waiting may also be suggested when the risks of surgery, radiation therapy, or hormonal therapy outweigh the possible benefits. | ||
| Line 6: | Line 12: | ||
Source: [http://www.cancer.gov/ncicancerbulletin/041911/page2 ncicancerbulletin] & [http://www.jurology.com/article/S0022-5347%2805%2962425-1/abstract Urology-Journal] | Source: [http://www.cancer.gov/ncicancerbulletin/041911/page2 ncicancerbulletin] & [http://www.jurology.com/article/S0022-5347%2805%2962425-1/abstract Urology-Journal] | ||
| + | |||
| + | <br> | ||
| + | <br> | ||
| + | To go back to the previous page, click [http://dolcera.com/wiki/index.php?title=Prostate_cancer_details#Treatment.2FManagement here] | ||
Latest revision as of 21:16, 6 October 2011
To go back to the previous page, click here
- Active surveillance refers to observation and regular monitoring without invasive treatment. In the context of prostate disease this usually comprises regular PSA blood tests and prostate biopsies. Active surveillance is often used when an early stage, slow-growing prostate cancer is suspected. However, watchful waiting may also be suggested when the risks of surgery, radiation therapy, or hormonal therapy outweigh the possible benefits.
- Approximately one-third of men that choose active surveillance for early stage tumors eventually have signs of tumor progression, and they may need to begin treatment within three years.
- Study results in 2011 suggest active surveillance is the best choice for older 'low-risk' patients. For younger men, a trial of active surveillance may not mean avoiding treatment altogether, but may reasonably allow a delay of a few years or more
Source: ncicancerbulletin & Urology-Journal
To go back to the previous page, click here
